Letters to the Editor: Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy

Rheumatology (United Kingdom)

Volumn 55, Issue 11, 2016, Pages 2084-2085

  Sollima, Salvatore ^a   Milazzo, Laura ^a   Peri, Anna Maria ^a   Torre, Alessandro ^a   Antinori, Spinello ^a   Galli, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; DACLATASVIR; DASABUVIR; INTERFERON; OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR; PEGINTERFERON; RIBAVIRIN; RITUXIMAB; SIMEPREVIR; SOFOSBUVIR; VIRUS RNA; ANTIVIRUS AGENT; VIRUS DNA;

ADULT; AGED; ANTIVIRAL THERAPY; ARTHRALGIA; ASTHENIA; CLINICAL ARTICLE; EDITORIAL; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; MIXED CRYOGLOBULINEMIA VASCULITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PURPURA; RELAPSE; SKIN ULCER; SUSTAINED VIROLOGICAL RESPONSE; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRAL CLEARANCE; CHRONIC HEPATITIS C; COMPLICATION; CRYOGLOBULINEMIA; GENETICS; HEPATITIS C; VASCULITIS; VIROLOGY;

AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DNA, VIRAL; FEMALE; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; VASCULITIS;

EID: 84997109186     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kew268     Document Type: Editorial

References (8)

1. Terrier B, Cacoub P. Cryoglobulinemia vasculitis: an update. Curr Opin Rheumatol 2013;25:10-8.
2. Pietrogrande M, De Vita S, Zignego AL et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011;10:444-54.
3. Saadoun D, Resche Rigon M, Pol S et al. PegIFNa/ribavirin/ protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis. J Hepatol 2015;62:24-30.
4. Gragnani L, Fognani E, Piluso A et al. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology 2015;61:1145-53.
5. Makara M, Sulyok M, Csacsovszki O, Sulyok Z, Valyi-Nagy I. Successful treatment of HCV-associated cryoglobulinemia with ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin: a case report. J Clin Virol 2015;72:66-8.
6. Sise ME, Bloom AK, Wisocky J et al. Treatment of hepatitis c virus-associated mixed cryoglobulinemia with sofosbuvir-based direct-acting antiviral agents. Hepatology 2016;63:408-17.
7. Levine JW, Gota C, Fessler BJ, Calabrese LH, Cooper SM. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 2005;32:1164-7.
8. Landau DA, Saadoun D, Halfon P et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 2008;58:604-11.